Proportion of selected congenital heart defects attributable to recognized risk factors

Annals of Epidemiology

Volumn 26, Issue 12, 2016, Pages 838-845

  Simeone, Regina M ^a   Tinker, Sarah C ^a   Gilboa, Suzanne M ^a   Agopian, A J ^b   Oster, Matthew E ^a,c   Devine, Owen J ^a,d   Honein, Margaret A ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Carter Consulting Inc   (United States)

Author keywords

Heart defects, congenital; Hypoplastic left heart syndrome; Population attributable fraction; Tetralogy of Fallot

Indexed keywords

ADULT; ARTICLE; CONGENITAL HEART MALFORMATION; DIABETES MELLITUS; FALLOT TETRALOGY; FEMALE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; MALE; OBESITY; POPULATION; POPULATION ATTRIBUTABLE FRACTION; PRIORITY JOURNAL; RISK FACTOR; CASE CONTROL STUDY; NEWBORN; STATISTICAL MODEL; UNITED STATES;

CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT, NEWBORN; LOGISTIC MODELS; MALE; RISK FACTORS; TETRALOGY OF FALLOT; UNITED STATES;

EID: 84997712985     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2016.10.003     Document Type: Article

References (73)

1. [1] van der Linde, D., Konings, E.E., Slager, M.A., Witsenburg, M., Helbing, W.A., Takkenberg, J.J., et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58:21 (2011), 2241–2247.
2. [2] Hoffman, J.I., Kaplan, S., The incidence of congenital heart disease. J Am Coll Cardiol 39:12 (2002), 1890–1900.
3. [3] Hoffman, J.I., Kaplan, S., Liberthson, R.R., Prevalence of congenital heart disease. Am Heart J 147 (2004), 425–439.
4. [4] Reller, M.D., Strickland, M.J., Riehle-Colarusso, T., Mahle, W.T., Correa, A., Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 153:6 (2008), 807–813.
5. [5] Boneva, R.S., Botto, L.D., Moore, C.A., Yang, Q., Correa, A., Erickson, J.D., Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 103:19 (2001), 2376–2381.
6. [6] Gilboa, S.M., Salemi, J.L., Nembhard, W.N., Fixler, D.E., Correa, A., Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 122:22 (2010), 2254–2263.
7. [7] Dolk, H., Loane, M., Garne, E., European Surveillance of Congenital Anomalies Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 123:8 (2011), 841–849.
8. [8] Foster, E., Graham, T.P. Jr., Driscoll, D.J., Reid, G.J., Reiss, J.G., Russell, I.A., et al. Task force 2: special health care needs of adults with congenital heart disease. J Am Coll Cardiol 37:5 (2001), 1176–1183.
9. [9] van der Bom, T., Zomer, A.C., Zwinderman, A.H., Meijboom, F.J., Bouma, B.J., Mulder, B.J., The changing epidemiology of congenital heart disease. Nat Rev Cardiol 8:1 (2011), 50–60.
10. [10] Marino, B.S., Lipkin, P.H., Newburger, J.W., Peacock, G., Gerdes, M., Gaynor, J.W., et al. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation 126:9 (2012), 1143–1172.
11. [11] Simeone, R.M., Oster, M.E., Cassell, C.H., Armour, B.S., Gray, D.T., Honein, M.A., Pediatric inpatient hospital resource use for congenital heart defects. Birth Defects Res A Clin Mol Teratol 100:12 (2014), 934–943.
12. [12] Connor, J.A., Gauvreau, K., Jenkins, K.J., Factors associated with increased resource utilization for congenital heart disease. Pediatrics 116:3 (2005), 689–695.
13. [13] Moons, P., Siebens, K., De Geest, S., Abraham, I., Budts, W., Gewillig, M., A pilot study of expenditures on, and utilization of resources in, health care in adults with congenital heart disease. Cardiol Young 11:3 (2001), 301–313.
14. [14] Gurvitz, M., Valente, A.M., Broberg, C., Cook, S., Stout, K., Kay, J., et al. Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol 61:21 (2013), 2180–2184.
15. [15] Warnes, C.A., Williams, R.G., Bashore, T.M., Child, J.S., Connolly, H.M., Dearani, J.A., et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 52:23 (2008), e143–e263.
16. [16] Pasquali, S.K., Jacobs, M.L., Assessment of costs in congenital heart surgery. World J Pediatr Congenit Heart Surg 5:3 (2014), 363–364.
17. [17] Parker, S.E., Mai, C.T., Canfield, M.A., Rickard, R., Wang, Y., Meyer, R.E., et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88:12 (2010), 1008–1016.
18. [18] Correa, A., Gilboa, S.M., Besser, L.M., Botto, L.D., Moore, C.A., Hobbs, C.A., et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol 199:3 (2008), 237.e1–237.e9.
19. [19] Correa, A., Gilboa, S.M., Botto, L.D., Moore, C.A., Hobbs, C.A., Cleves, M.A., et al. Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol 206:3 (2012), 218.e1–218.e13.
20. [20] Simeone, R.M., Devine, O.J., Marcinkevage, J.A., Gilboa, S.M., Razzaghi, H., Bardenheier, B.H., et al. Diabetes and congenital heart defects: a systematic review, meta-analysis, and modeling project. Am J Prev Med 48:2 (2015), 195–204.
21. [21] Gilboa, S.M., Correa, A., Botto, L.D., Rasmussen, S.A., Waller, D.K., Hobbs, C.A., et al. Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol 202:1 (2010), 51.e1–51.e10.
22. [22] Waller, D.K., Shaw, G.M., Rasmussen, S.A., Hobbs, C.A., Canfield, M.A., Siega-Riz, A.M., et al. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 161:8 (2007), 745–750.
23. [23] Cai, G.J., Sun, X.X., Zhang, L., Hong, Q., Association between maternal body mass index and congenital heart defects in offspring: a systematic review. Am J Obstet Gynecol 211:2 (2014), 91–117.
24. [24] Burn, J., Brennan, P., Little, J., Holloway, S., Coffey, R., Somerville, J., et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351:9099 (1998), 311–316.
25. [25] Chin-Yee, N.J., Costain, G., Swaby, J.A., Silversides, C.K., Bassett, A.S., Reproductive fitness and genetic transmission of tetralogy of Fallot in the molecular age. Circ Cardiovasc Genet 7:2 (2014), 102–109.
26. [26] Wang, X., Wang, J., Zhao, P., Guo, Y., Wu, L., Sun, J., et al. Familial congenital heart disease: data collection and preliminary analysis. Cardiol Young 23:3 (2013), 394–399.
27. [27] Loffredo, C.A., Chokkalingam, A., Sill, A.M., Boughman, J.A., Clark, E.B., Scheel, J., et al. Prevalence of congenital cardiovascular malformations among relatives of infants with hypoplastic left heart, coarctation of the aorta, and d-transposition of the great arteries. Am J Med Genet A 124A:3 (2004), 225–230.
28. [28] Hinton, R.B. Jr., Martin, L.J., Tabangin, M.E., Mazwi, M.L., Cripe, L.H., Benson, D.W., Hypoplastic left heart syndrome is heritable. J Am Coll Cardiol 50:16 (2007), 1590–1595.
29. [29] Broussard, C.S., Rasmussen, S.A., Reefhuis, J., Friedman, J.M., Jann, M.W., Riehle-Colarusso, T., et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol 204:4 (2011), 314.e1–314.e11.
30. [30] Crider, K.S., Cleves, M.A., Reefhuis, J., Berry, R.J., Hobbs, C.A., Hu, D.J., Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 163:11 (2009), 978–985.
31. [31] Alwan, S., Reefhuis, J., Rasmussen, S.A., Olney, R.S., Friedman, J.M., Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:26 (2007), 2684–2692.
32. [32] Coughlin, S.S., Benichou, J., Weed, D.L., Attributable risk estimation in case-control studies. Epidemiol Rev 16:1 (1994), 51–64.
33. [33] Darrow, L.A., Steenland, N.K., Confounding and bias in the attributable fraction. Epidemiology 22:1 (2011), 53–58.
34. [34] Ruckinger, S., von Kries, R., Toschke, A.M., An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors. BMC Med Res Methodol, 9, 2009, 7.
35. [35] Eide, G.E., Gefeller, O., Sequential and average attributable fractions as aids in the selection of preventive strategies. J Clin Epidemiol 48:5 (1995), 645–655.
36. [36] Agopian, A.J., Tinker, S.C., Lupo, P.J., Canfield, M.A., Mitchell, L.E., Proportion of neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol 97:1 (2013), 42–46.
37. [37] Yoon, P.W., Rasmussen, S.A., Lynberg, M.C., Moore, C.A., Anderka, M., Carmichael, S.L., et al. The National Birth Defects Prevention Study. Public Health Rep 116:Suppl 1 (2001), 32–40.
38. [38] Reefhuis, J., Gilboa, S.M., Anderka, M., Browne, M.L., Feldkamp, M.L., Hobbs, C.A., et al. The National Birth Defects Prevention Study: a review of the methods. Birth Defects Res A Clin Mol Teratol 103 (2015), 656–669.
39. [39] Botto, L.D., Lin, A.E., Riehle-Colarusso, T., Malik, S., Correa, A., the National Birth Defects Prevention Study. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79:10 (2007), 714–727.
40. [40] Garne, E., Loane, M., Dolk, H., Barisic, I., Addor, M.C., Arriola, L., et al. Spectrum of congenital anomalies in pregnancies with pregestational diabetes. Birth Defects Res A Clin Mol Teratol 94:3 (2012), 134–140.
41. [41] Loffredo, C.A., Wilson, P.D., Ferencz, C., Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64:2 (2001), 98–106.
42. [42] Bell, R., Glinianaia, S.V., Tennant, P.W., Bilous, R.W., Rankin, J., Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia 55:4 (2012), 936–947.
43. [43] Watkins, M.L., Rasmussen, S.A., Honein, M.A., Botto, L.D., Moore, C.A., Maternal obesity and risk for birth defects. Pediatrics 111:5 Pt 2 (2003), 1152–1158.
44. [44] Madsen, N.L., Schwartz, S.M., Lewin, M.B., Mueller, B.A., Prepregnancy body mass index and congenital heart defects among offspring: a population-based study. Congenit Heart Dis 8:2 (2013), 131–141.
45. [45] Mills, J.L., Troendle, J., Conley, M.R., Carter, T., Druschel, C.M., Maternal obesity and congenital heart defects: a population-based study. Am J Clin Nutr 91:6 (2010), 1543–1549.
46. [46] Alverson, C.J., Strickland, M.J., Gilboa, S.M., Correa, A., Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics 127:3 (2011), e647–e653.
47. [47] Malik, S., Cleves, M.A., Honein, M.A., Romitti, P.A., Botto, L.D., Yang, S., et al. Maternal smoking and congenital heart defects. Pediatrics 121:4 (2008), e810–e816.
48. [48] Oster, M.E., Riehle-Colarusso, T., Alverson, C.J., Correa, A., Associations between maternal fever and influenza and congenital heart defects. J Pediatr 158:6 (2011), 990–995.
49. [49] Botto, L.D., Panichello, J.D., Browne, M.L., Krikov, S., Feldkamp, M.L., Lammer, E., et al. Congenital heart defects after maternal fever. Am J Obstet Gynecol 210:4 (2014), 359.e1–359.e11.
50. [50] Zierler, S., Rothman, K.J., Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med 313:6 (1985), 347–352.
51. [51] Kallen, B.A., Otterblad Olausson, P., Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17:3 (2003), 255–261.
52. [52] Czeizel, A.E., Rockenbauer, M., Sorensen, H.T., Olsen, J., The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 15:6 (2001), 637–646.
53. [53] Czeizel, A.E., Puho, E., Sorensen, H.T., Olsen, J., Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy. Congenit Anom 44:2 (2004), 79–86.
54. [54] Waller, D.K., Gallaway, M.S., Taylor, L.G., Ramadhani, T.A., Canfield, M.A., Scheuerle, A., et al. Use of oral contraceptives in pregnancy and major structural birth defects in offspring. Epidemiology 21:2 (2010), 232–239.
55. [55] Block, S.R., Watkins, S.M., Salemi, J.L., Rutkowski, R., Tanner, J.P., Correia, J.A., et al. Maternal pre-pregnancy body mass index and risk of selected birth defects: evidence of a dose-response relationship. Paediatr Perinat Epidemiol 27:6 (2013), 521–531.
56. [56] Brite, J., Laughon, S.K., Troendle, J., Mills, J., Maternal overweight and obesity and risk of congenital heart defects in offspring. Int J Obes 38:6 (2014), 878–882.
57. [57] Michalski, A.M., Richardson, S.D., Browne, M.L., Carmichael, S.L., Canfield, M.A., VanZutphen, A.R., et al. Sex ratios among infants with birth defects, National Birth Defects Prevention Study, 1997-2009. Am J Med Genet A 167A:5 (2015), 1071–1081.
58. [58] Lisi, A., Botto, L.D., Rittler, M., Castilla, E., Bianca, S., Bianchi, F., et al. Sex and congenital malformations: an international perspective. Am J Med Genet A 134A:1 (2005), 49–57.
59. [59] Pradat, P., Francannet, C., Harris, J.A., Robert, E., The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol 24:3 (2003), 195–221.
60. [60] Canfield, M.A., Honein, M.A., Yuskiv, N., Xing, J., Mai, C.T., Collins, J.S., et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 76:11 (2006), 747–756.
61. [61] Kucik, J.E., Alverson, C.J., Gilboa, S.M., Correa, A., Racial/ethnic variations in the prevalence of selected major birth defects, metropolitan Atlanta, 1994-2005. Public Health Rep 127:1 (2012), 52–61.
62. [62] Shuler, C.O., Tripathi, A., Black, G.B., Park, Y.M., Jerrell, J.M., Individual risk factors and complexity associated with congenital heart disease in a pediatric medicaid cohort. South Med J 106:7 (2013), 385–390.
63. [63] Erickson, J.D., Risk factors for birth defects: data from the Atlanta Birth Defects Case-Control Study. Teratology 43:1 (1991), 41–51.
64. [64] Blomberg, M.I., Kallen, B., Maternal obesity and morbid obesity: the risk for birth defects in the offspring. Birth Defects Res A Clin Mol Teratol 88:1 (2010), 35–40.
65. [65] Wemakor, A., Casson, K., Garne, E., Bakker, M., Addor, M.C., Arriola, L., et al. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Eur J Epidemiol 30 (2015), 1187–1198.
66. [66] Louik, C., Lin, A.E., Werler, M.M., Hernandez-Diaz, S., Mitchell, A.A., First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356:26 (2007), 2675–2683.
67. [67] Tararbit, K., Lelong, N., Houyel, L., Bonnet, D., Goffinet, F., Khoshnood, B., Assessing the role of multiple pregnancies in the association between tetralogy of Fallot and assisted reproductive techniques: a path-analysis approach. Orphanet J Rare Dis, 9, 2014, 27.
68. [68] Reefhuis, J., Honein, M.A., Schieve, L.A., Correa, A., Hobbs, C.A., Rasmussen, S.A., the National Birth Defects Prevention Study. Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod 24:2 (2009), 360–366.
69. [69] Duong, H.T., Hoyt, A.T., Carmichael, S.L., Gilboa, S.M., Canfield, M.A., Case, A., et al. Is maternal parity an independent risk factor for birth defects?. Birth Defects Res A Clin Mol Teratol 94:4 (2012), 230–236.
70. [70] Eide, G.E., Attributable fractions for partitioning risk and evaluating disease prevention: a practical guide. Clin Respir J 2:Suppl 1 (2008), 92–103.
71. [71] Llorca, J., Delgado-Rodriguez, M., A comparison of several procedures to estimate the confidence interval for attributable risk in case-control studies. Stat Med 19:8 (2000), 1089–1099.
72. [72] van Buuren, S., Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16:3 (2007), 219–242.
73. [73] Little, R.J.A., Statistical analysis with missing data. 1987, John Wiley & Sons, Inc., New York.